Arrowhead Pharmaceuticals, Inc. (ARWR) Social Stream

Arrowhead Pharmaceuticals, Inc. (ARWR)

Today's Latest Price: $57.30 USD

0.79 (-1.36%)

Updated Oct 30 4:00pm

Add ARWR to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 384 in Biotech

See all "A" rated Strong Buy stocks

Featured Post From StockTwits About ARWR

$ARWR Goldman meeting with ceo highlights from Goldman

Reiterate more patient data at AASLD in November and engagement with FDA in 2021 to reduce study 2/3 length from 2yr to 1yr
AHA conference in November data for ang3 and apoc3. Lover dose frequency (quarter or semi) and better safety than competition
Enac data in 1H21 with proof of concept at year end 2020. Target 10% of population and those that can't take trikafta so 15% of population total or 25%. Can't tell. Promising preclinical safety profile reiterated. Arolung2 goal of filing cta by 2020ye. Arwr plans to address numerous indications here since lung is target rich (asthma, fibrosis....).
Arohif2 entering clinic mid 2021 and an additional lung asset target in 2021. New extra hepatic every 18-24months. Could work across many tumors and make a franchise!!!!
Partner strategically. 10 assets clinical mid 2021 and 20 by 2023/2024 in order to focus on ang3, apoc3, enac and lung2
Arohsd ph2 pending positive ph1 data 1h21
skeezbag, published October 29, 2020

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4776 seconds.